- Back to menuPrices
- Back to menuResearch
- Back to menu
- Back to menu
- Back to menu
- Back to menuResearch
Latest from Omkar Godbole
Bitcoin’s Options Market Shows Strongest Bullish Mood on Record
Bitcoin's options market is in the midst of its strongest bullish sentiment on record as the cryptocurrency rallies to three-year highs.

First Mover: Bitcoin Breaches $16K as (Committed) Holders Diss Dalio's Diss
Hedge fund titan Ray Dalio says bitcoin could be due for a reckoning. It didn't bother bitcoin: Prices rallied and holders are holding on.

98% of Bitcoin's 'Unspent Outputs' Are Worth More Than When Made
The percentage of bitcoin unspent transaction outputs (UTXOs) in profit recently topped 98%, the highest level since December 2017.

First Mover: Bitcoin Pause, Ethereum Snafu, 1,000% Returns Put Focus on Exchange Tokens
Binance Coin and exchange tokens are popping as bitcoin's rally shows signs of temporary exhaustion and Ethereum gets snared in blockchain split.

Number of Bitcoin ATMs Up 85% This Year as Coronavirus Drives Adoption
The number of bitcoin ATMs across the globe has surged amid a coronavirus-induced shift toward contactless payments.

Bitcoin Likely to Consolidate Before December Rise Toward $20K, Say Analysts
The bitcoin market is likely to take a breather before continuing its rise toward $20,000 the end of the year, analysts told CoinDesk.

First Mover: Bitcoin Needs No Vaccine as Druckenmiller Lays Down 'Better Bet'
Price reaction to vaccine breakthrough renews dialogue over whether bitcoin trades like a risk-on asset, inflation hedge or neither.

3 Reasons Bitcoin Has Rallied Over 60% in Just Two Months
We've all watched bitcoin rally sharply since September. But what's driving the bull market?

First Mover: What's Next for Bitcoin as Wall Street Gets Vaccine Booster
Crypto markets could turn on a shift in economic policies as U.S. President-Elect Joe Biden's transition team starts to meet.

Markets Spike as Coronavirus Vaccine Trial Shows 90% Success Rate
Bitcoin and U.S. stock futures shot up on Monday after Pfizer announced positive results from a trial of its coronavirus vaccine.
